Lung Cancer Survival Gains: Contributions of Academia and Industry

Affiliation

• ¹ Bishal Gyawali, M.D., Ph.D., is with the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, the Anticancer Fund, Belgium, and the Department of Oncology and Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada. Gauthier Bouche, M.D., M.P.H., is with the Anticancer Fund, Belgium Pan Pantziarka, Ph.D.,is with the Anticancer Fund, Belgium. Aaron S. Kesselheim, M.D., J.D., M.P.H., is with the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Ameet Sarpatwari, Ph.D., J.D., is with the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.